MD Anderson Cancer Center /ID# 202187 — Houston, Texas

MD Anderson Cancer Center /ID# 202187 is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center /ID# 202187 has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors, Cancer, Hematologic Malignancies.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center /ID# 202187?

MD Anderson Cancer Center /ID# 202187 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center /ID# 202187 conducted?

MD Anderson Cancer Center /ID# 202187 has 1 clinical trials on record. Their work covers Advanced Solid Tumors, Cancer, Hematologic Malignancies.

Is MD Anderson Cancer Center /ID# 202187 accredited by Crixeo Health?

MD Anderson Cancer Center /ID# 202187 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center /ID# 202187?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.